Skip to Main Content
Insider Trading

Last Updated: 1 day, 9 hours ago

Jonathan Violin has an estimated net worth of at least $13.6 million*, as of June 11, 2025. They own 480,905 shares of VRDN stock. They have sold 200,000 shares of VRDN stock since 2021, for an estimated $6.1 million.

Jonathan Violin $VRDN SEC Form 4 Insider Trading

Jonathan Violin has filed a total of 10 insider trades in $VRDN since 2021. Their most recent trade was a sale of 50,000 shares, made on Feb 02, 2023. Their largest trade was a sale of 50,000 shares, made on Feb 02, 2023. We estimate that they now own 480,905 shares of $VRDN, worth an estimated $7.5 million.



Insider Trading at $VRDN

There have been a total of 37 insider trades reported at $VRDN since 2021, with 3.6 million shares purchased and 378,514 shares sold. The most active insider traders in $VRDN stock have been Jonathan Violin, Lara Meisner, and Lara Meisner. The most recent trade was a purchase of 5,000 shares reported by Thomas W. Beetham (Chief Operating Officer), made on Sep 27, 2024.



History of Insider Stock Trades by Jonathan Violin

Company Ticker Purchase / Sale Shares Date Disclosed (EST)
VRDN logo VRDN Sale 50,000 Feb 02, 2023 Feb. 3, 2023, 7:12 p.m.
VRDN logo VRDN Sale 30,000 Jun 01, 2022 June 1, 2022, 8 p.m.
VRDN logo VRDN Sale 30,000 May 02, 2022 May 4, 2022, 5:23 p.m.
VRDN logo VRDN Sale 26,400 Apr 01, 2022 April 5, 2022, 6:09 p.m.
VRDN logo VRDN Sale 3,600 Apr 04, 2022 April 5, 2022, 6:09 p.m.
VRDN logo VRDN Sale 18,894 Mar 01, 2022 March 2, 2022, 8 p.m.
VRDN logo VRDN Sale 11,106 Mar 02, 2022 March 2, 2022, 8 p.m.
VRDN logo VRDN Sale 12,340 Feb 02, 2022 Feb. 3, 2022, 7:11 p.m.
VRDN logo VRDN Sale 909 Feb 03, 2022 Feb. 3, 2022, 7:11 p.m.
VRDN logo VRDN Sale 16,751 Feb 01, 2022 Feb. 3, 2022, 7:11 p.m.




$VRDN Executives and Stock Owners with Insider Trades



*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.